Status:

TERMINATED

Retreatment Study of Galiximab + Rituximab in Follicular Non-Hodgkin's Lymphoma (NHL)

Lead Sponsor:

Biogen

Conditions:

Lymphoma, Non-Hodgkin's

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

This is a Phase III, multicenter, global, open-label, single-arm, retreatment study of an investigational drug called galiximab in combination with an approved drug called rituximab in subjects with r...

Eligibility Criteria

Inclusion

  • Key
  • Demonstrated a response (CR, CRu, or PR) on Study 114-NH-301 (Galiximab in combination with Rituximab compared with Rituximab in combination with Placebo) and then relapsed or progressed with a TTP \>=6 months. Relapsed disease is defined as documented disease progression using the International Workshop Response Criteria (IWRC).
  • Bidimensionally measurable disease with at least 1 lesion \>=2.0 cm in a single dimension.
  • Acceptable hematologic, hepatic, and renal function.
  • Key

Exclusion

  • Any lymphoma therapy between Final Visit on Study 114-NH-301 and Study Day 1 of this retreatment study.
  • Chronic or intermittent corticosteroids for inflammatory or autoimmune disorders within 3 weeks prior to Study Day 1.
  • Transfusion-dependent subjects.
  • Presence of central nervous system (CNS) lymphoma.
  • Histologic transformation.
  • Presence of pleural or peritoneal effusion with positive cytology for lymphoma.
  • Another primary malignancy requiring active treatment.
  • Serious nonmalignant disease (e.g., congestive heart failure, hydronephrosis); active uncontrolled bacterial, viral, or fungal infections; or other conditions that would compromise protocol objectives in the opinion of the Investigator and/or the Sponsor.
  • New York Heart Association Class III or IV cardiac disease or myocardial infarction within 6 months prior to Study Day 1.

Key Trial Info

Start Date :

November 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2010

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT00384150

Start Date

November 1 2007

End Date

January 1 2010

Last Update

November 26 2015

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.